Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, versus $0.01 reported last year. Revenue for the quarter came in at $8.8 million, versus $7.9 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.